Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The ...

SnapLogic, the leader in generative integration, today announced the launch of its next-generation API management (APIM) solution, helping organizations acce ...

The biotech is buying up APIM Therapeutics, a fellow clinical-stage, Norway-based oncology company that has a lead candidate in phase 1/2 and phase 2 trials, the Nordic announced Thursday.